The RI investment comes on the back of three other recently completed transactions in Malaysia and Singapore in the last two months
Former Novo Nordisk and Pharmanovia executive to lead next growth phase in NAD diagnostics and personalised health innovation
The newly formed SAB will provide strategic direction across research, clinical development, and regulatory pathways
The FDA approval makes PD-L1 IHC 22C3 pharmDx the only companion diagnostic approved to detect tumors expressing PD-L1 in esophageal or GEJ carcinoma patients for KEYTRUDA treatmen
This approval represents the seventh FDA-approved companion diagnostic indication for PD-L1 IHC 22C3 pharmDx with KEYTRUDA
Mehta brings strong leadership experience in biopharmaceuticals, life science research, and diagnostics
Covaris is a global leader in the development and deployment of end-to-end solutions for high-throughput genomic and proteomic analysis
Apollo continues to invest in genomics technology and research for better patient care
Alpenglow has created an end-to-end 3D spatial biology solution including patented high-throughput 3D imaging
Through this partnership, Premas will connect with genomics labs to provide automated NGS solutions
Subscribe To Our Newsletter & Stay Updated
